Concepedia

Author

Guy Houillon

Sanofi (France)

Also Known As

G Houillon, G. Houillon, Guy Houillon

28

Publications

256

Citations

10

H-Index

20

Concepts

All Affiliations

Sanofi (France)Catholic University of KoreaSeverance HospitalResearch Institute for Tropical MedicineNational Health Insurance Service
GH

About

Guy Houillon is an author at Sanofi (France) specializing in vaccination, vaccine safety, and vaccine development.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

45

2

Epidemiology

2

2

67

3

Immunology

2

2

45

4

Public Health

1

1

33

5

International Health

1

1

33

Guy Houillon

×

9

Publications

184

Citations

9

H-Index

YearCitations

A randomized study of the immunogenicity and safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in comparison with SA14-14-2 Vaccine in children in the Republic of Korea

Dong Soo Kim, Guy Houillon, Gwang Cheon Jang,

Human Vaccines & Immunotherapeutics

2014

34

Towards rabies elimination in the Asia-Pacific region: From theory to practice

Charles E. Rupprecht, Bernadette Abela-Ridder, Ronello Abila,

Biologicals

2020

33

Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina

Carlos Espul, Laura Benedetti, Héctor Cuello,

Hepatic Medicine Evidence and Research

2012

25

Post-licensure, phase IV, safety study of a live attenuated Japanese encephalitis recombinant vaccine in children in Thailand

Tawee Chotpitayasunondh, Pornpimol Pruekprasert, Thanyawee Puthanakit,

Vaccine

2016

22

Persistence of Rabies Virus-Neutralizing Antibodies after Vaccination of Rural Population following Vampire Bat Rabies Outbreak in Brazil

Rita Medeiros, Viviane Jusot, Guy Houillon,

PLoS neglected tropical diseases

2016

18

Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine

A. V. Moisseeva, I. L. Marichev, N. A. Biloschitchkay,

Journal of Viral Hepatitis

2008

17

Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines

Beatriz P. Quiambao, Cristina Ambas, Sherylle Diego,

Vaccine

2019

14

One-week intramuscular or intradermal pre-exposure prophylaxis with human diploid cell vaccine or Vero cell rabies vaccine, followed by simulated post-exposure prophylaxis at one year: A phase III, open-label, randomized, controlled trial to assess immunogenicity and safety

Beatriz P. Quiambao, Jonathan G. Lim, Valérie Bosch Castells,

Vaccine

2022

11

Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea

Dong Soo Kim, Gwang Cheon Jang, Sung Ho,

The Pediatric Infectious Disease Journal

2015

10

Page 1